SCHEMBL6490912

SCHEMBL6490912

CC(C)(OS(C)(=O)=O)C(N)=O

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1289185 0.80 CA2 (0.30)
Sulfuric Acid SCHEMBL25288324 0.78 KDM4E (0.32)
SCHEMBL2335624 0.77 TSHR (0.36) USP2TSHR
SCHEMBL1369430 0.77 USP2 (0.32) USP2TSHR
SCHEMBL3441320 0.73 DGAT1 (0.38) USP2TSHR
SCHEMBL1780391 0.73 MEN1 (0.31)
SCHEMBL2598120 0.71 DGAT1 (0.41)
SCHEMBL1273951 0.69 LMNA (0.35) TSHR
SCHEMBL10012648 0.69
Acrylamide SCHEMBL28300376 0.69 ALDH1A1 (0.46) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3697784-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS Galapagos NV (BE) 2020-08-26 EP disclosed
WO-2019076716-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS GALAPAGOS NV (BE) 2019-04-25 WO disclosed
US-6864268-B2 β3 adrenergic receptor agonists PFIZER INC. (US) 2005-03-08 US disclosed
US-5280128-A Diazotization, cyclization 3-(2'-aminophenylthio)benzanthrone CASSELLA AKTIENGESELLSCHAFT (DE) 1994-01-18 US disclosed